Trajectories of crystallized cognition over 28 years: Testing the neurodegenerative hypothesis of schizophrenia
Schizophrenia Research · 2026-08 · 294 · 110-115
DOI: 10.1016/j.schres.2026.04.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2026-08. Verfasst von Kevin Hazelton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Stony Brook University, Stony Brook, NY, United States of America. Electronic address: kshazelton@gmail.com. Hauptthemen laut MEDLINE: Schizophrenia, Schizophrenic Psychology, Psychotic Disorders, Cognition Disorders. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Introduction
Cognitive impairment is common among individuals with schizophrenia. However, it is unclear whether these impairments reflect perturbed neurodevelopmental or neurodegenerative processes. While crystallized cognition is expected to increase over the lifespan, neurodegenerative processes are associated with stalled or declining trajectories of crystallized cognition. Trajectories of crystallized cognition may therefore provide a window into the nature of cognitive impairment in schizophrenia. Previous studies have been limited by small sample sizes, brief follow-up periods, and a lack of data extending into midlife. The present study charted trajectories of crystallized cognition in schizophrenia and other psychotic disorders.
Methods
Participants are from the Suffolk County Mental Health Project, an epidemiological first-admission psychosis cohort. Vocabulary scores were used as a measure of crystallized cognition. Scores were collected from 2-, 20-, 25-, and 28-year follow-ups, and data from 297 people who had vocabulary scores at 2 or more follow-ups were analyzed. Vocabulary score trajectories were estimated using hierarchical linear models.
Results
Individuals with schizophrenia did not accrue vocabulary (B=0.01, 95% C.I.=(−0.02, 0.03), p=0.631), while those with other psychotic disorders gained one point every 25 years (B=0.04, 95% C.I.=(0.02, 0.06), p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Stony Brook University, Stony Brook, NY, United States of America. Electronic address: kshazelton@gmail.com.
- Department of Psychiatry, Stony Brook University, Stony Brook, NY, United States of America.
- Department of Family, Population, and Preventive Medicine/Program in Public Health, Stony Brook University, Stony Brook, NY, United States of America.
Förderung
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Hazelton, K., Stein, A., Gallardo, M., Fernandes, D., Clouston, S., Kotov, R., & Jonas, K. (2026). Trajectories of crystallized cognition over 28 years: Testing the neurodegenerative hypothesis of schizophrenia. Schizophrenia Research, 294, 110-115. https://doi.org/10.1016/j.schres.2026.04.019
Vancouver
Hazelton K, Stein A, Gallardo M, Fernandes D, Clouston S, Kotov R, et al. Trajectories of crystallized cognition over 28 years: Testing the neurodegenerative hypothesis of schizophrenia. Schizophrenia Research. 2026;294:110-115. doi:10.1016/j.schres.2026.04.019
BibTeX
@article{Hazelton2026,
author = {Hazelton, Kevin and Stein, Alexandra and Gallardo, Marcela and Fernandes, David and Clouston, Sean and Kotov, Roman and Jonas, Katherine},
title = {Trajectories of crystallized cognition over 28 years: Testing the neurodegenerative hypothesis of schizophrenia},
journal = {Schizophrenia Research},
year = {2026},
volume = {294},
pages = {110--115},
doi = {10.1016/j.schres.2026.04.019}
}
EUVIMED